Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

US Patent 8101619 · Granted Jan 24, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spiro-cyclic amine derivatives as S1P modulators2022
Spiro-cyclic amine derivatives as S1P modulators2020
Spiro-cyclic amine derivatives as S1P modulators2019
Spiro-cyclic amine derivatives as S1P modulators2018
(Thio)morpholine derivatives as S1P modulators2016
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2015
(Thio)morpholine derivatives as S1P modulators2015
1H-imidazole derivatives as cannabinoid CB2 receptor modulators2015
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2014
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2014
Heterocyclic compounds with affinity to muscarinic receptors2014
Heterocyclic compounds with affinity to muscarinic receptors2014